Medical Bulletin 24/ April/ 2025 Dr. Bhumika Maikhuri24 April 2025 3:00 PM ISTHere are the top medical news for the day:Alarming Rise in Children’s Anxiety and Depression: Study FindsThe percentage of children under 18 years old...
New Research Links Blood Pressure Intervention to Lower Dementia Risks Dr. Bhumika Maikhuri24 April 2025 8:30 AM ISTA large-scale international study has found that people who receive intensive support to manage high blood pressure are significantly less likely to...
Semaglutide 2.4 mg Reduces Need for Antihypertensive and Lipid-Lowering Medications in Obesity Treatment: Study Finds Medha Baranwal12 Feb 2025 9:00 AM ISTUSA: A recent analysis of five randomized controlled trials from the STEP program found that adults using semaglutide for obesity were more likely to...
Servier Introduces Cosyrel: A Novel SPC for Hypertension and Post-MI Care Deeksha Bhandari16 Jan 2025 2:59 PM ISTServier India Pvt. Ltd. has launched a single-pill combination (SPC) of Bisoprolol/Perindopril in India under the brand name Cosyrel, which is...
Hypertension: KARDIA-1 trial suggests zilebesiran potentially effective antihypertensive with quarterly or biannual dosing Medha Baranwal21 Feb 2024 7:15 PM ISTUSA: RNA interference with zilebesiran can significantly lower blood pressure for up to 6 months, indicating potential for use as an effective...
Azelnidipine Demonstrates Efficacy in Lowering BP in Indian Patients with Hypertension: Study Dr Riya Dave17 Feb 2024 10:30 AM ISTHypertension (HTN) is a prevalent cardiovascular condition with significant morbidity and mortality worldwide. Azelnidipine, a selective calcium...
Single injection of zilebesiran effective in lowering BP for six months in hypertension patients: KARDIA-1 trial Medha Baranwal29 Nov 2023 10:00 AM ISTUSA: New data from the KARDIA-1 Phase 2 study showed that a single injection of the investigational antihypertensive agent zilebesiran was effective...
Ajanta Pharma Launches World's 1st FDC Met XL AMT for Patients with Uncontrolled Hypertension and Cardiovascular Co-morbidity in India MD Brand Connect8 Aug 2023 11:53 AM ISTAjanta Pharma, one of the leaders in the cardiology segment has announced the launch of Met XL AMT, a novel triple drug combination for the...
Green space visits associated with less frequent use of certain prescription medicines Dr. Shravani Dali23 Jan 2023 8:00 PM ISTResearchers have found in a new study that frequent green space visits are associated with less frequent use of psychotropic, antihypertensive, and...
Migraine patients treated with anti-CGRP receptor antibodies at risk of developing high BP Aditi8 Dec 2022 10:00 AM ISTNetherlands: A study published in Neurology has concluded that migraine patients are at risk of developing high blood pressure when treated with...
Akum Pharma gets CDSCO panel nod to manufacture, market antihypertensive FDC drug Dr. Divya Colin27 Nov 2022 11:45 AM ISTNew Delhi: The Subject Expert Committee SEC, functional under the Central Drug Standard Control Organization CDSCO, has approved Akum Pharma to...
Dosing schedule and duration not defined: CDSCO panel tells Windlas Biotech on antihypertensive FDC Drug Dr. Divya Colin1 Oct 2022 5:00 PM ISTNew Delhi: Citing that dosing schedule and duration was not defined, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
